These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2672652

  • 21. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
    Loskot F, Novotny P, Sucic P, Schneider G.
    Z Kardiol; 1989; 78 Suppl 5():89-93. PubMed ID: 2698569
    [Abstract] [Full Text] [Related]

  • 22. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M, Fischer A, Turina J, Hess OM.
    Praxis (Bern 1994); 1997 Nov 19; 86(47):1849-53. PubMed ID: 9480502
    [Abstract] [Full Text] [Related]

  • 23. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
    Scardi S, Pandullo C, Pivotti F, Ceschia G, Pollavini G.
    G Ital Cardiol; 1986 Nov 19; 16(11):895-903. PubMed ID: 3104123
    [Abstract] [Full Text] [Related]

  • 24. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U, Blasini R.
    Herz; 1986 Feb 19; 11(1):55-61. PubMed ID: 2870014
    [Abstract] [Full Text] [Related]

  • 25. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
    Weidemann H, Schuon J, Schober B.
    Z Kardiol; 1983 Feb 19; 72 Suppl 3():229-32. PubMed ID: 6666226
    [Abstract] [Full Text] [Related]

  • 26. [Isosorbide dinitrate in coronary heart disease. Effects of a delayed-action preparation during acute load and in chronic use].
    Westermann KW, Eggert R, Kugler G, Priester G.
    Med Klin; 1975 Aug 29; 70(35):1375-9. PubMed ID: 1177792
    [Abstract] [Full Text] [Related]

  • 27. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P, Vlasínová J, Manousek J, Semrád B, Rysavý F, Lupínek Z, Meluzín J, Vlasicová I, Pirochtová I, Bocek O.
    Vnitr Lek; 1993 Sep 29; 39(9):856-64. PubMed ID: 8212639
    [Abstract] [Full Text] [Related]

  • 28. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
    Gibelli G, Negrini M, Bruno AM, Fiorini GL, Lambiase M, Magenta G, Corti D, Prina L, Pollavini PG, De Ponti C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep 29; 27(9):436-41. PubMed ID: 2509380
    [Abstract] [Full Text] [Related]

  • 29. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R, Johnen R, Vydra L, Solbach C.
    Pharmatherapeutica; 1986 Sep 29; 4(8):486-95. PubMed ID: 3086899
    [Abstract] [Full Text] [Related]

  • 30. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study.
    Colombo G, Favini G, Aglieri S, Pollavini G, de Vita C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr 29; 23(4):211-4. PubMed ID: 3922903
    [Abstract] [Full Text] [Related]

  • 31. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM, Ohlmeier H, Mannebach H, Kabelitz K, Gleichmann U.
    Herz; 1985 Jun 29; 10(3):172-81. PubMed ID: 3926614
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study].
    Odenthal HJ, Thürmann P, Wiechmann HW, Josephs W, Lenga P.
    Z Kardiol; 1991 Jun 29; 80(6):392-6. PubMed ID: 1926985
    [Abstract] [Full Text] [Related]

  • 33. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
    Wagner F, Gohlke-Bärwolf C, Trenk D, Jähnchen E, Roskamm H.
    Eur Heart J; 1991 Sep 29; 12(9):994-9. PubMed ID: 1936012
    [Abstract] [Full Text] [Related]

  • 34. [New drug forms of isosorbide dinitrate: the problem of an objective evaluation in patients with ischemic heart disease].
    Martsevich SIu, Metelitsa VI, Kozyreva MP, Blagodatskikh SV, Simkhaev LS, Piotrovskiĭ VK.
    Farmakol Toksikol; 1991 Sep 29; 54(3):53-6. PubMed ID: 1915825
    [Abstract] [Full Text] [Related]

  • 35. [Disparate efficacy of isosorbide dinitrate, in sustained-release form, during acute and chronic administration (author's transl)].
    Blasini R, Brügmann U, Mannes A, Froer KL, Hall D, Rudolph W.
    Herz; 1980 Oct 29; 5(5):298-305. PubMed ID: 7450664
    [No Abstract] [Full Text] [Related]

  • 36. [Interval therapy in effective treatment of angina pectoris using nitroglycerin patch systems. A controlled study with determination of nitroglycerin plasma levels].
    Reiniger G, Menke G, Boertz A, Kraus F, Rudolph W.
    Herz; 1987 Feb 29; 12(1):68-73. PubMed ID: 3104180
    [Abstract] [Full Text] [Related]

  • 37. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A, Meshulam R, Schlesinger Z.
    Cardiology; 1991 Feb 29; 79 Suppl 2():31-40. PubMed ID: 1760827
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
    Saito M, Nobuyoshi M, Nakamura N, Nishiyama S, Haze K, Hiramori K, Ikeda M.
    Arzneimittelforschung; 1983 Feb 29; 33(9):1301-5. PubMed ID: 6685512
    [Abstract] [Full Text] [Related]

  • 39. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U, Blasini R, Rudolph W.
    Herz; 1984 Aug 29; 9(4):244-52. PubMed ID: 6434387
    [Abstract] [Full Text] [Related]

  • 40. [Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches].
    Reiniger G, Rudolph W.
    Herz; 1987 Oct 29; 12(5):348-53. PubMed ID: 3119443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.